Drugs becoming eligible for first Paragraph IV ANDA filing in 2030
Drugs expiring in 2031
Drugs that contains Pramipexole Dihydrochloride
Drugs that contains Pyridostigmine Bromide
Cormedix patents expiration
Neurocrine patents expiration
Drugs that contains Tirbanibulin
Drugs that contains Lutetium Lu 177 Dotatate
